Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
113.47B | 103.72B | 97.38B | 118.44B | 117.55B | Gross Profit |
29.11B | 24.48B | 21.96B | 50.29B | 48.54B | EBIT |
7.45B | 3.78B | 1.61B | 4.18B | 2.92B | EBITDA |
13.11B | 9.26B | 6.45B | 9.24B | 8.98B | Net Income Common Stockholders |
5.57B | 3.07B | 1.10B | 3.37B | 1.88B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
17.39B | 19.59B | 16.18B | 14.79B | 13.26B | Total Assets |
95.84B | 94.23B | 87.63B | 78.87B | 78.05B | Total Debt |
3.69B | 5.34B | 5.75B | 1.36B | 1.19B | Net Debt |
-13.71B | -14.23B | -10.43B | -13.43B | -11.95B | Total Liabilities |
34.34B | 37.80B | 34.09B | 28.31B | 30.39B | Stockholders Equity |
61.49B | 56.43B | 53.54B | 50.56B | 47.66B |
Cash Flow | Free Cash Flow | |||
-294.00M | 4.46B | -3.60B | 2.29B | -1.87B | Operating Cash Flow |
6.53B | 9.81B | 2.12B | 8.05B | 3.39B | Investing Cash Flow |
-6.47B | -5.29B | -6.74B | -5.63B | -5.61B | Financing Cash Flow |
-2.23B | -1.18B | 3.97B | -932.00M | -2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥54.50B | 15.71 | 2.50% | 11.18% | 28.19% | ||
76 Outperform | ¥63.35B | 11.41 | 1.42% | 9.41% | 80.83% | ||
70 Neutral | ¥34.64B | 10.68 | 1.01% | 11.13% | 7.80% | ||
67 Neutral | ¥61.04B | 37.63 | 1.26% | 3.75% | 44.95% | ||
64 Neutral | $8.82B | 14.56 | 4.78% | 173.92% | 3.50% | 2.20% | |
62 Neutral | ¥31.66B | 14.38 | 1.49% | 7.17% | 45.25% | ||
61 Neutral | ¥35.66B | 24.53 | 1.62% | 3.10% | -15.65% |